Novanta Inc.

Novanta Inc.

NOVT
Novanta Inc.US flagNASDAQ Global Select
160.53
USD
-1.88
- -
5.72BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
9.3
10.62
10.8
11.09
14.97
17.6
17.87
16.81
19.97
24.15
24.6
26.4
26.8
26.68
Basic EPS, GAAP
0.21
-0.71
1.03
0.63
1.72
1.41
1.16
1.27
1.42
2.08
2.03
1.78
1.47
1.43
Free Cash Flow per Basic Share
1.3
1.07
0.81
1.02
1.56
2.15
1.5
3.62
1.98
1.91
2.79
3.93
1.32
1.82
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
6.54
5.78
6.78
7.39
8.5
9.87
11.01
12.24
13.57
15.55
17.5
19.23
20.37
20.35
Tangible Book Value per Share
3.11
1.55
2.17
2.57
-1.57
0.22
-0.68
1.2
-5.06
-2.16
1.23
-0.67
13.29
13.21
Basic Weighted Avg Shares
34
34
35
35
35
35
35
35
35
36
36
36
37
38
Sales/Revenue/Turnover
317
365
374
385
521
614
626
591
707
861
882
949
981
1,005
Operating Margin (%)
7.84
7.29
9.95
10.63
12.49
12.87
11.48
10.11
11.61
12.48
13.99
13.09
11.9
11.63
Depreciation Expense
20
24
19
20
31
37
38
38
43
53
47
56
62
63
Net Income, GAAP
7
-24
36
22
60
49
41
45
50
74
73
64
54
54
Effective Tax Rate (%)
38.33
- -
22.58
32.34
18.16
16.65
10.91
8.02
10.4
15.04
12.98
18.94
22.71
22.79
Profit Margin (%)
2.31
-6.65
9.53
5.72
11.52
7.99
6.51
7.54
7.12
8.6
8.27
6.75
5.49
5.35
Working Capital
140
129
128
129
190
178
170
190
190
256
276
266
570
566
LT Debt
64
115
98
79
226
210
264
234
480
476
391
456
254
240
Total Equity
242
211
245
259
312
368
417
477
521
578
673
746
1,314
1,311
Return on Invested Capital (%)
5.14
- -
8.38
7.89
11.84
11.59
10.01
7.67
8.38
8.7
9.91
8.7
6.32
6.36
Return on Capital (%)
3.36
- -
10.79
6.46
13.24
8.65
6.68
6.61
6.07
7.34
7.02
5.84
4.87
4.86
Return on Common Equity (%)
3.33
-11.5
16.45
8.97
21.74
15.33
11.17
10.92
11.06
14.31
12.33
9.72
7.49
7.26

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
16
48
50
LT Borrowings
446
213
201
LT Finance Leases
43
41
39
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
36
36
36
Market Capitalization
3,605
4,351
4,448

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
468
783
787
Cash, Cash Equivalents & STI
89
381
389
Accounts Receivable, Net
171
185
174
Inventories
180
188
193
Total Current Liabilities
187
212
221
Payables & Accruals
127
120
116
ST Debt
16
48
50
Deferred Revenue
8
11
16

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.56%
24.74%
76.25%
Free Cash Flow
20.52%
-5.08%
-65.74%
Net Income, GAAP
13.92%
6.11%
-16.01%
Sales/Revenue/Turnover
10.74%
10.97%
3.3%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
231
236
244
238
949
2025
233
241
248
258
981
2026
258
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.41
0.38
0.53
0.46
1.78
2025
0.59
0.12
0.3
0.46
1.47
2026
0.52
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

MCPAPIChat
CEO
Matthijs Glastra
Full Time Employees
3,000
Sector
Technology
Industry
Hardware, Equipment & Parts
Address
125 Middlesex Turnpike Bedford MA United States of America 01730
IPO Date
Mar 24, 1999
Business
Novanta Inc. (Nasdaq: NOVT), headquartered in Bedford, Massachusetts and incorporated in 1968 as General Scanning Inc., designs, manufactures and markets core technology solutions that enable original equipment manufacturers in medical and advanced industrial markets to achieve competitive advantages through extreme precision and performance; the company combines proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. Its Automation Enabling Technologies segment offers laser beam delivery components and solutions such as galvanometers and polygon scanners from Cambridge Technology, CO2, solid-state and ultrafast lasers from Synrad and Laser Quantum, optical and inductive encoders from Celera Motion and Zettlex, precision motors and integrated stepper motors from Celera Motion, Applimotion and IMS, servo drives and motion control solutions from Celera Motion and Ingenia, intelligent robotic end-of-arm tooling including tool changers, force-torque sensors and material removal tools from ATI Industrial Automation, and air bearing spindles from Westwind, serving applications in advanced industrial processes, robotics, medical laser procedures and life science automation; the Medical Solutions segment provides medical insufflators, endoscopic pumps and disposables from WOM, video processing and streaming from NDS and Med X Change, touch panel displays from Reach Technology, machine vision technologies from JADAK, RFID and barcode identification technologies from JADAK and ThingMagic, thermal chart recorders from JADAK, light and color measurement devices from Photo Research, laser beam delivery solutions from Laser Quantum, and advanced motion control solutions from Motion Solutions, targeting minimally invasive surgery, medical imaging, diagnostics and industrial vision systems. Novanta operates globally with manufacturing facilities and sales offices across North America, Europe and Asia-Pacific, employing approximately 3,000 people and serving OEM customers in diverse industries including healthcare, life sciences, semiconductor manufacturing, industrial robotics and advanced automation. Recent developments include the January 2024 acquisition of Motion Solutions Parent Corp. for $192 million to enhance precision motion offerings in medical applications, a realignment of reportable segments in the fourth quarter of 2024 to Automation Enabling Technologies and Medical Solutions, completion of a $550 million tangible equity units offering in November 2025 to repay debt, fund acquisitions and support working capital, and expansion of its share repurchase program by $200 million.

Company News

MCPAPIChat
  • Novanta Inc. (NOVT) M&A Call Transcript

  • Novanta Inc. Announces $300 Million Private Placement

  • Novanta Inc. Announces Acquisition of Riverpoint Medical

  • A Look at Novanta Inc (NOVT) After 5.1% Gain -- GF Value $153.89 vs Price $164.34

  • A Look at Novanta Inc (NOVT) After 3.1% Gain -- GF Value $154.22 vs Price $159.70

  • A Look at Novanta Inc (NOVT) After 4.0% Gain -- GF Value $154.26 vs Price $153.60

  • Here's Why Novanta (NOVT) Looks Ripe for Bottom Fishing

  • Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026

  • Novanta to Present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026

  • Novanta Inc. (NOVT) Q1 2026 Earnings Call Transcript

  • Novanta Q1 Earnings Call Highlights

  • Novanta (NOVT) Q1 Earnings and Revenues Surpass Estimates

  • Novanta Announces Financial Results for the First Quarter 2026

  • Novanta Inc (NOVT) Shares Fall 6.3% -- What GF Score of 92 Tells Investors

  • Novanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference Call

  • Novanta Inc. $NOVT Shares Acquired by Allspring Global Investments Holdings LLC

  • Congress Asset Management Co. Has $72.82 Million Position in Novanta Inc. $NOVT

  • Novanta Joins NVIDIA Halos AI Systems Inspection Lab

  • Capital International Investors Sells 620,843 Shares of Novanta Inc. $NOVT

  • Blair William & Co. IL Decreases Stock Holdings in Novanta Inc. $NOVT